Effects of different mark-up drug policies on drug-related expenditures in tertiary public hospitals: an interrupted time series study in Shanghai, China, 2015-2018-Reference-Cited by-同舟云学术

Effects of different mark-up drug policies on drug-related expenditures in tertiary public hospitals: an interrupted time series study in Shanghai, China, 2015-2018

Published:2020-02-29 Issue:1 Volume:14 Page:16-22
ISSN:1881-7815
Container-title:BioScience Trends
language:en
Short-container-title:BST

Author:

Wang Xianji¹,Li Fen²,Wang Xuemei³,Zhang Xinping³,Liu Chenxi³,Wang Dan³,Wang Haiyin²,Chen Yingyao¹

Affiliation:

1. Key Lab of Health Technology Assessment, National Health Commission, School of Public Health, Fudan University, Shanghai, China.

2. Shanghai Health Development Research Center, Shanghai, China.

3. School of Medicine and Health Management, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China.

Publisher

International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine,Health(social science)

Link

https://www.jstage.jst.go.jp/article/bst/14/1/14_2019.01350/_pdf

Reference38 articles.

1. 2. Mao W, Vu H, Xie Z, Chen W, Tang S. Systematic review on irrational use of medicines in China and Vietnam. PLoS One. 2015; 10:e0117710.

2. 3. Hitchen L. Adverse drug reactions result in 250,000 UK admissions a year. BMJ. 2006; 332:1109.

3. 4. World Health Organization. Measuring medicine prices, availability, affordability and price components 2nd edition. 2008; http://www.haiweb.org/medicineprices/manual/documents.html (accessed September 1, 2019).

4. 5. Ben-Aharon O, Shavit O, Magnezi R. Does drug price-regulation affect healthcare expenditures. Eur J Health Econ. 2017; 18:859-867.

5. 6. OECD/WHO. Pharmaceutical expenditure, in OECD/WHO. Health at a Glance: Asia/Pacific 2012. Paris: OECD Publishing. http://dx.doi.org/10.1787/9789264183902-32-en (Accessed November 27, 2019)

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review of policies regulating or removing mark-ups in the pharmaceutical supply and distribution chain;Health Policy;2023-12

2. Effects of price cap regulation on pharmaceutical supply chain under the zero markup drug policy;Operational Research;2023-09-13

3. The impact of China's zero markup drug policy on drug costs for managing Parkinson's disease and its complications: an interrupted time series analysis;Frontiers in Public Health;2023-05-09

4. How Did Zero-Markup Medicines Policy Change Prescriptions in the Eyes of Patients?—A Retrospective Quasi-Experimental Analysis;International Journal of Environmental Research and Public Health;2022-09-27

5. Did the universal zero-markup drug policy lower healthcare expenditures? Evidence from Changde, China;BMC Health Services Research;2021-11-06